article · Life Sciences

Retraction notice to “In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma” [Life Sciences 285 (2021) 119961]

2026Damietta University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Cassava research and cyanide
Natural Antidiabetic Agents Studies
Pharmacology and Obesity Treatment

Sustainable Development Goals

Zero Hunger

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.lfs.2026.124268

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.